Bristol-Myers Squibb to Take Part in Cowen and Company 38th Annual Global Health Care Conference

Monday, March 5, 2018 6:59 am EST

Dateline:

NEW YORK

Public Company Information:

NYSE:
BMY

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) will participate in the Cowen and Company 38th Annual Global Health Care Conference on Monday, March 12, 2018, in Boston. Giovanni Caforio, chairman and chief executive officer and Fouad Namouni, head of oncology development will answer questions about the company at 2:50 p.m. ET.

Investors and the general public are invited to listen to a live webcast of the session at http://investor.bms.com. An archived edition of the session will be available later that day.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, and YouTube.

Contact:

Bristol-Myers Squibb Company
Media:
Ken Dominski, 609-252-5251
ken.dominski@bms.com
or
Investors:
Tim Power, 609-252-7509
timothy.power@bms.com
or
Bill Szablewski, 609-252-5894
william.szablewski@bms.com

$Cashtags

Privacy Policy
Business Wire NewsHQsm